期刊文献+

HOXA7在口腔鳞状细胞癌组织中的表达及临床意义 被引量:3

Expression and clinical significance of HOXA7 in the Oral Squamous Cell Carcinoma
下载PDF
导出
摘要 目的研究同源盒基因A7(homeobox protein hox-A7,HOXA7)mRNA在口腔鳞状细胞癌组织(oral squamous cell carcinoma,OSCC)中的表达。方法收集20例口腔正常粘膜组织及42例OSCC组织,利用实时荧光定量聚合酶链反应(real-time quantitative program control register,Real-Time q PCR)检测HOXA7mRNA的相对表达情况。结果对比口腔黏膜组织,HOXA7mRNA在OSCC中高表达(z=-5.739,P<0.050),不同分化程度(z=-0.863,P<0.05),不同临床分期(z=-0.756,P<0.05),组间差异有统计学意义。不同年龄(z=-0.619,P>0.05)、不同性别(z=-1.801,P>0.05),组间差异无统计学意义。结论 HOXA7mRNA在口腔鳞状细胞癌组织中高表达,并且与肿瘤分化和临床分期有关,HOXA7可能作为口腔癌治疗和口腔鳞癌早期诊断的潜在生物标记物。 Objective To detect the expression of homeobox A7(HOXA7)gene mRNA in oral squamous cell carcinoma(OSCC).Method Real-time absolute quantitative PCR(qPCR)detected the expression of HOXA7 mRNA in 42 OSCC and 20 normaloral mucosa tissues.Results HOXA7 mRNA was found to be highly expressed in OSCC(z=-5.739,P〈0.05)and its mRNA correlated significantly with the different degree of differentiation(z=-0.863,P〈0.05)and clinical stage(z=-0.756,P〈0.05).But did not find any significant differences in age(z=-0.619,P〉0.05)and gender(z=-1.801,P〉0.05).Conclusion The study found that HOXA7 gene mRNA are highly expressed in OSCC and that the expression level is correlated with the degree of tumor differentiation and clinical stages.The findings implicate HOXA7 as potential targets for cancer therapeutics and as early OSCC diagnostic biomarkers.
出处 《贵州医药》 CAS 2017年第9期902-904,共3页 Guizhou Medical Journal
基金 贵州省国际合作计划项目(编号:黔科合外G字[2014]7009号) 广州市医药卫生科技一般引导项目(2017 14011327) 2016年广州医科大学科研项目2016A31
关键词 同源盒基因A7 口腔鳞状细胞癌 实时定量荧光聚合酶链反应 HOXA7 Oral Squamous Cell Careinoma Real-Time PCR
  • 相关文献

参考文献3

二级参考文献43

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1056
  • 2马冠生,朱丹红,胡小琪,栾德春,孔灵芝,杨晓光.中国居民饮酒行为现况[J].营养学报,2005,27(5):362-365. 被引量:195
  • 3Weir HK,Thun MJ,Hankey BF,Ries LA,Howe HL,Wingo PA,Jemal A,Ward E,Anderson RN,Edwards BK.Annual report to the nation on the status of cancer,1975-2000,featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst 2003; 95:1276-1299
  • 4Greenlee RT,Murray T,Bolden S,Wingo PA.Cancer statistics,2000.CA Cancer J Clin 2000; 50:7-33
  • 5August DA,Ottow RT,Sugarbaker PH.Clinical perspective of human colorectal cancer metastasis.Cancer Metastasis Rev 1984; 3:303-324
  • 6Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell 1990; 61:759-767
  • 7Cho KR,Vogelstein B.Genetic alterations in the adenoma--carcinoma sequence.Cancer 1992; 70:1727-1731
  • 8Vogelstein B,Kinzler KW.The multistep nature of cancer.Trends Genet 1993; 9:138-141
  • 9Smith G,Carey FA,Beattie J,Wilkie MJ,Lightfoot TJ,Coxhead J,Garner RC,Steele RJ,Wolf CR.Mutations in APC,Kirsten-ras,and p53--alternative genetic pathways to colorectal cancer.Proc Natl Acad Sci USA 2002; 99:9433-9438
  • 10Ambros V.microRNAs:tiny regulators with great potential.Cell 2001; 107:823-826

共引文献158

同被引文献31

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部